Xconomy | Seattle - Business + Technology in the Exponential Economy

Biotech, VC, deals

Vaccsys Raises $9M in Series A

Gregory T. Huang 6/19/08

Vaccsys, a vaccine maker based in Seattle, has called down $9 million of an $18 million Series A round, according to Private Equity Hub, which cites a regulatory filing. The investors include Alta Partners, The Column Group, and Versant Ventures (all based in California).

Gregory T. Huang is the Editor of Xconomy Seattle. You can e-mail him at gthuang@xconomy.com or call 206-624-2249.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.